Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
- PMID: 34171931
- DOI: 10.1055/a-1491-1771
Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
Abstract
Background: Hepatic steatosis is a condition frequently encountered in clinical practice, with potential progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. Detection and staging of hepatic steatosis are of most importance in nonalcoholic fatty liver disease (NAFLD), a disease with a high prevalence of more than 1 billion individuals affected. Ultrasound (US) is one of the most used noninvasive imaging techniques used in the diagnosis of hepatic steatosis. Detection of hepatic steatosis with US relies on several conventional US parameters, which will be described. US is the first-choice imaging in adults at risk for hepatic steatosis. The use of some scoring systems may add additional accuracy especially in assessing the severity of hepatic steatosis.
Summary: In the presented paper, we discuss screening and risk stratification, ultrasound features for diagnosing hepatic steatosis, B-mode criteria, focal fatty patterns and Doppler features of the hepatic vessels, and the value of the different US signs for the diagnosis of liver steatosis including classifying the severity of steatosis using different US scores. Limitations of conventional B-mode and Doppler features in the evaluation of hepatic steatosis are also discussed, including those in grading and assessing the complications of steatosis, namely fibrosis and nonalcoholic steatohepatitis.
Key messages: Ultrasound is the first-line imaging examination for the screening and follow-up of patients with liver steatosis. The use of some scoring systems may add additional accuracy in assessing the severity of steatosis. Conventional B-mode and Doppler ultrasound have limitations in grading and assessing the complications of steatosis.
HINTERGRUND: die Fettleber ist eine in der klinischen Praxis häufige Erkrankung mit dem Risiko ein Leberfibrose, Leberzirrhose und auch ein hepatozelluläres Karzinom (HCC) zu entwickeln. Die nicht-alkoholische Fettlebererkrankung (NAFLD) ist eine Krankheit mit hoher Prävalenz und mit mehr als einer Milliarde betroffener Personen. Der Nachweis und die Stadieneinteilung sind von prognostischer Bedeutung. Ultraschall (US) ist eine weitverbreitete nichtinvasive Bildgebungstechnik, die auch bei der Diagnose der Fettleber eingesetzt werden kann. Der Nachweis einer Fettleber beruht zunächst auf anamnestischen Angaben und konventionellen sonografischen Zeichen. Die Verwendung von Bewertungssystemen kann die diagnostische Genauigkeit erhöhen, insbesondere bei der Beurteilung des Schweregrads.In dem vorgestellten Artikel diskutieren wir Screening und auch die Risikostratifizierung für die Entwicklung einer Steatohepatitis, Leberfibrose und eines HCC. Die Ultraschallmerkmale zur Diagnose und Differenzialdiagnose der Fettleber inklusive von B-Mode-Kriterien und Doppler-Charakteristika von Lebergefäßen werden erläutert. Die Klassifizierung des Schweregrads der Steatose wird anhand von US-Scores beschrieben und deren Einschränkungen diskutiert. KERNBOTSCHAFT : Ultraschall ist die erste bildgebende Untersuchungstechnik für das Screening und Follow-up von Patienten mit Fettleber. Die Verwendung von Bewertungssystemen kann die Diagnostik verbessern.
Thieme. All rights reserved.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 14;20(22):6821-5. doi: 10.3748/wjg.v20.i22.6821. World J Gastroenterol. 2014. PMID: 24944472 Free PMC article. Review.
-
Radiologic evaluation of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392. World J Gastroenterol. 2014. PMID: 24966609 Free PMC article. Review.
-
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13. Clin Ther. 2021. PMID: 34400007 Review.
-
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.Gastroenterology. 2016 Jun;150(8):1811-1822.e4. doi: 10.1053/j.gastro.2016.03.008. Epub 2016 Mar 19. Gastroenterology. 2016. PMID: 27003601
-
Liver hemodynamic patterns in nonalcoholic steatosis: Doppler ultrasonography and histological evaluation.Minerva Gastroenterol Dietol. 2016 Mar;62(1):19-29. Minerva Gastroenterol Dietol. 2016. PMID: 26887796
Cited by
-
Ultrasound-guided attenuation parameter for identifying metabolic dysfunction-associated steatotic liver disease: a prospective study.Ultrasonography. 2025 Mar;44(2):134-144. doi: 10.14366/usg.24204. Epub 2024 Dec 19. Ultrasonography. 2025. PMID: 39935289 Free PMC article.
-
Inter-System Variability of Eight Different Handheld Ultrasound (HHUS) Devices-A Prospective Comparison of B-Scan Quality and Clinical Significance in Intensive Care.Diagnostics (Basel). 2023 Dec 26;14(1):54. doi: 10.3390/diagnostics14010054. Diagnostics (Basel). 2023. PMID: 38201363 Free PMC article.
-
Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal.Diagnostics (Basel). 2022 Sep 22;12(10):2287. doi: 10.3390/diagnostics12102287. Diagnostics (Basel). 2022. PMID: 36291976 Free PMC article. Review.
-
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)].Z Gastroenterol. 2023 Aug;61(8):1028-1036. doi: 10.1055/a-1957-5671. Epub 2023 Feb 15. Z Gastroenterol. 2023. PMID: 36791784 Free PMC article. German.
-
An Optimized Strategy Based on Conventional Ultrasound for Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease.Diagnostics (Basel). 2023 Nov 22;13(23):3503. doi: 10.3390/diagnostics13233503. Diagnostics (Basel). 2023. PMID: 38066744 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical